FDA OKs Antibody Combo for Milder COVID-19

(MedPage Today) -- Two monoclonal antibodies administered together, bamlanivimab and etesevimab, received emergency use authorization (EUA) for mild to moderate COVID-19 patients at risk of severe disease, the FDA said late Tuesday.
The treatment...